DFT-383

N/A

Report date: 2025/05/17 20:00:09

Base Information

Drug NameDFT-383
Drug Alias NameDFT-383DFT383
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapyCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionCTNS gene stimulants
TargetsCystinosin
Therapy Area/IndicationsCystinosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis AgNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsCystinosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A